|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM371371422 |
| 003 |
DE-627 |
| 005 |
20240914232426.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
240424s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1093/jxb/erae147
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1533.xml
|
| 035 |
|
|
|a (DE-627)NLM371371422
|
| 035 |
|
|
|a (NLM)38648173
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Přibylová, Adéla
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a How to use CRISPR/Cas9 in plants
|b from target site selection to DNA repair
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 11.09.2024
|
| 500 |
|
|
|a Date Revised 14.09.2024
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Experimental Biology.
|
| 520 |
|
|
|a A tool for precise, target-specific, efficient, and affordable genome editing is a dream for many researchers, from those who conduct basic research to those who use it for applied research. Since 2012, we have tool that almost fulfils such requirements; it is based on clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) systems. However, even CRISPR/Cas has limitations and obstacles that might surprise its users. In this review, we focus on the most frequently used variant, CRISPR/Cas9 from Streptococcus pyogenes, and highlight key factors affecting its mutagenesis outcomes: (i) factors affecting the CRISPR/Cas9 activity, such as the effect of the target sequence, chromatin state, or Cas9 variant, and how long it remains in place after cleavage; and (ii) factors affecting the follow-up DNA repair mechanisms including mostly the cell type and cell cycle phase, but also, for example, the type of DNA ends produced by Cas9 cleavage (blunt/staggered). Moreover, we note some differences between using CRISPR/Cas9 in plants, yeasts, and animals, as knowledge from individual kingdoms is not fully transferable. Awareness of these factors can increase the likelihood of achieving the expected results of plant genome editing, for which we provide detailed guidelines
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a CRISPR/Cas
|
| 650 |
|
4 |
|a Cell cycle
|
| 650 |
|
4 |
|a DNA repair
|
| 650 |
|
4 |
|a cleavage
|
| 650 |
|
4 |
|a editing
|
| 650 |
|
4 |
|a mutagenesis
|
| 650 |
|
4 |
|a plants
|
| 650 |
|
4 |
|a post-cleavage trimming
|
| 650 |
|
4 |
|a staggered ends
|
| 700 |
1 |
|
|a Fischer, Lukáš
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Journal of experimental botany
|d 1985
|g 75(2024), 17 vom: 11. Sept., Seite 5325-5343
|w (DE-627)NLM098182706
|x 1460-2431
|7 nnns
|
| 773 |
1 |
8 |
|g volume:75
|g year:2024
|g number:17
|g day:11
|g month:09
|g pages:5325-5343
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1093/jxb/erae147
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 75
|j 2024
|e 17
|b 11
|c 09
|h 5325-5343
|